CareFusion touts FDA OK for Viking on Nicolet EDX system
San Diego, Calif.-based medical device maker CareFusion (NYSE:CFN) won FDA clearance for its Viking on Nicolet electrodiagnostic system, a multi-modality device that monitors and tests the body’s electrophysiological functions.
The next-gen EDX system provides feedback in a variety of reporting formats for nerve conduction studies, electromyography, evoked potential testing and intra-operative monitoring, according to a press release.
The FDA nod is more good news for CareFusion, which this month won a $75 million contract from the U.S. Defense Dept. and won an honorable mention on CNN Money’s list of the most admired companies, and last month touted a $44.7 million DOD contract for infusion pumps.
The regulatory win didn’t do much for CareFusion on Wall Street, however, where CFN shares were down 1¢ to $25.65 as of about 2:45 p.m. today. Read more